{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T07:23:04Z","timestamp":1777879384942,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012478","name":"National University of Cordoba Secretariat of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ejpb.2026.115026","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T16:01:52Z","timestamp":1771516912000},"page":"115026","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["From ascorbic acid to N-acetylcysteine: self-assembled clarithromycin liquid crystals as a new generation of carrier-free antibiotics"],"prefix":"10.1016","volume":"222","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8418-7401","authenticated-orcid":false,"given":"Antonela","family":"Bartolilla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2968-7737","authenticated-orcid":false,"given":"Ariana","family":"Zoppi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7697-8839","authenticated-orcid":false,"given":"Brenda","family":"Basiglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3189-9886","authenticated-orcid":false,"given":"Marcela R.","family":"Longhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4616-7434","authenticated-orcid":false,"given":"Virginia","family":"Aiassa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2026.115026_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.126255","article-title":"Carrier-free cholesteric liquid crystal and xerogel of clarithromycin-ascorbic acid with enhanced antimicrobial and antibiofilm activity","volume":"685","author":"Bartolilla","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115026_b0010","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ejps.2017.02.003","article-title":"Dissolution and dissolution\/permeation experiments for predicting systemic exposure following oral administration of the BCS class II drug clarithromycin","volume":"101","author":"Forner","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115026_b0015","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2165\/00003495-199244010-00009","article-title":"Clarithromycin","volume":"44","author":"Peters","year":"1992","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115026_b0020","doi-asserted-by":"crossref","first-page":"634","DOI":"10.18203\/2320-6012.ijrms20240027","article-title":"Clarithromycin: overview and its current clinical utility in the treatment of respiratory tract infections","volume":"12","author":"Naik","year":"2024","journal-title":"Int. J. Res. Med. Sci."},{"key":"10.1016\/j.ejpb.2026.115026_b0025","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2025.1524452","article-title":"Global prevalence of macrolide-resistant Staphylococcus spp.: a comprehensive systematic review and meta-analysis","volume":"16","author":"Navidifar","year":"2025","journal-title":"Front. Microbiol."},{"issue":"8","key":"10.1016\/j.ejpb.2026.115026_b0030","doi-asserted-by":"crossref","first-page":"900","DOI":"10.3390\/antibiotics10080900","article-title":"N-Acetylcysteine protects bladder epithelial cells from bacterial invasion and displays antibiofilm activity against urinary tract bacterial pathogens","volume":"10","author":"Manoharan","year":"2021","journal-title":"Antibiotics (basel)"},{"key":"10.1016\/j.ejpb.2026.115026_b0035","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9949453","article-title":"N-Acetylcysteine: a review of clinical usefulness (an old drug with new tricks)","volume":"2021","author":"Schwalfenberg","year":"2021","journal-title":"J. Nutr. Metab."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115026_b0040","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3390\/ph15020217","article-title":"N-acetylcysteine (NAC) and its role in clinical practice management of cystic fibrosis (CF): a review","volume":"15","author":"Guerini","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.ejpb.2026.115026_b0045","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ijpharm.2017.03.079","article-title":"Clarithromycin and N-acetylcysteine co-spray-dried powders for pulmonary drug delivery: a focus on drug solubility","volume":"533","author":"Manniello","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.ejpb.2026.115026_b0050","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1378\/chest.09-0132","article-title":"Respiratory microbiology of patients with cystic fibrosis in the United States, 1995 to 2005","volume":"136","author":"Razvi","year":"2009","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115026_b0055","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00281-011-0291-7","article-title":"Immunopathogenesis of Staphylococcus aureus pulmonary infection","volume":"34","author":"Parker","year":"2012","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.ejpb.2026.115026_b0060","doi-asserted-by":"crossref","unstructured":"M. Pivard, K. Moreau, F. Vandenesch, Staphylococcus aureus arsenal to conquer the lower respiratory tract, mSphere 6 (3) (2021) e00059-21. DOI: 10.1128\/mSphere.00059-21.","DOI":"10.1128\/mSphere.00059-21"},{"key":"10.1016\/j.ejpb.2026.115026_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2023.102867","article-title":"Lipidic lyotropic liquid crystals: insights on biomedical applications","volume":"313","author":"Blanco-Fern\u00e1ndez","year":"2023","journal-title":"Adv. Colloid Interface Sci."},{"issue":"16","key":"10.1016\/j.ejpb.2026.115026_b0070","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.3390\/polym16162293","article-title":"An up-to-date overview of liquid crystals and liquid crystal polymers for different applications: a review","volume":"16","author":"Guardi\u00e0","year":"2024","journal-title":"Polymers (basel)"},{"issue":"13","key":"10.1016\/j.ejpb.2026.115026_b0075","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1021\/cm8006952","article-title":"Self-assembly of amino-acid-based dendrons: organogels and lyotropic and thermotropic liquid crystals","volume":"20","author":"Kuang","year":"2008","journal-title":"Chem. Mater."},{"issue":"5","key":"10.1016\/j.ejpb.2026.115026_b0080","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0079-6700(96)00014-7","article-title":"Molecular self-organization of amphotropic liquid crystals","volume":"21","author":"Tschierske","year":"1996","journal-title":"Prog. Polym. Sci."},{"issue":"23","key":"10.1016\/j.ejpb.2026.115026_b0085","article-title":"Advanced functional liquid crystals","volume":"34","author":"Uchida","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ejpb.2026.115026_b0090","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1039\/b807346e","article-title":"Supramolecular gelling agents: can they be designed?","volume":"37","author":"Dastidar","year":"2008","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejpb.2026.115026_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2024.125260","article-title":"Liquid crystal gelators based on tetrathiafulvalene supramolecular assemblies: synthesis, characterization and potential application","volume":"407","author":"Hou","year":"2024","journal-title":"J. Mol. Liq."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115026_b0100","doi-asserted-by":"crossref","DOI":"10.1002\/asia.202200972","article-title":"Bio-Polypropylene and polypropylene-based biocomposites: solutions for a sustainable future","volume":"18","author":"Wang","year":"2023","journal-title":"Chem. Asian J."},{"issue":"6","key":"10.1016\/j.ejpb.2026.115026_b0105","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3390\/gels8060334","article-title":"Insights into the role of biopolymer-based xerogels in biomedical applications","volume":"8","author":"Abdul Khalil","year":"2022","journal-title":"Gels"},{"issue":"24","key":"10.1016\/j.ejpb.2026.115026_b0110","doi-asserted-by":"crossref","first-page":"6154","DOI":"10.1016\/j.biomaterials.2010.04.002","article-title":"Self-assembling nanostructures to deliver angiogenic factors to pancreatic islets","volume":"31","author":"Chow","year":"2010","journal-title":"Biomaterials"},{"issue":"26","key":"10.1016\/j.ejpb.2026.115026_b0115","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1002\/anie.200604203","article-title":"Discotic liquid crystals: from tailor-made synthesis to plastic electronics","volume":"46","author":"Laschat","year":"2007","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ejpb.2026.115026_b0120","first-page":"97","article-title":"Polymorphism of lipid-water systems","volume":"vol. 1","author":"Seddon","year":"1995"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115026_b0125","doi-asserted-by":"crossref","DOI":"10.1088\/1742-6596\/1410\/1\/012057","article-title":"Estimation of particle size using the Debye equation and the Scherrer formula for polyphasic TiO powder","volume":"1410","author":"Bokuniaeva","year":"2019","journal-title":"J. Phys. Conf. Ser."},{"key":"10.1016\/j.ejpb.2026.115026_b0130","unstructured":"Clinical and Laboratory Standards Institute M100 (CLSI). Performance standards for antimicrobial susceptibility testing. CLSI document M02-M100. 2025. Ed.35."},{"key":"10.1016\/j.ejpb.2026.115026_b0135","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. CLSI document M07-M100. 2025. Ed.35."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115026_b0140","doi-asserted-by":"crossref","first-page":"82","DOI":"10.14744\/eej.2020.29292","article-title":"Evaluation of the cytotoxicity and apoptotic effect of nano triple antibiotic paste with nano anti-inflammatory drug as an intracanal medicament","volume":"6","author":"Nashaat","year":"2021","journal-title":"Eur. Endod. J."},{"key":"10.1016\/j.ejpb.2026.115026_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.mimet.2024.107010","article-title":"Application of MTT assay for probing metabolic activity in bacterial biofilm-forming cells on nanofibrous materials","volume":"224","author":"Stindlova","year":"2024","journal-title":"J. Microbiol. Methods"},{"key":"10.1016\/j.ejpb.2026.115026_b0150","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/10587250008031036","article-title":"Bragg reflections in cholesteric liquid crystals: from selectivity to broadening and reciprocally","volume":"339","author":"Binet","year":"2000","journal-title":"Mol. Cryst. Liq. Cryst."},{"issue":"11","key":"10.1016\/j.ejpb.2026.115026_b0155","doi-asserted-by":"crossref","first-page":"7873","DOI":"10.3390\/ma8115427","article-title":"Chiral nematic structure of cellulose nanocrystal suspensions and films; polarized light and atomic force microscopy","volume":"8","author":"Gray","year":"2015","journal-title":"Materials (basel)"},{"key":"10.1016\/j.ejpb.2026.115026_b0160","series-title":"Textures of Liquid Crystals","author":"Dierking","year":"2003"},{"issue":"4","key":"10.1016\/j.ejpb.2026.115026_b0165","doi-asserted-by":"crossref","DOI":"10.1103\/PhysRevE.66.041701","article-title":"Evolution of disclinations in cholesteric liquid crystals","volume":"66","author":"Zhang","year":"2002","journal-title":"Phys. Rev. E"},{"key":"10.1016\/j.ejpb.2026.115026_b0170","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.electacta.2017.05.033","article-title":"Formation of physical-gel redox electrolytes through self-assembly of discotic liquid crystals: applications in dye sensitized solar cells","volume":"244","author":"Khan","year":"2017","journal-title":"Electrochim. Acta"},{"key":"10.1016\/j.ejpb.2026.115026_b0175","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.molliq.2018.01.160","article-title":"Morphological, optical and dielectric behavior of chiral nematic liquid crystal mixture: study on effect of different amount of chirality","volume":"255","author":"Jessy","year":"2018","journal-title":"J. Mol. Liq."},{"issue":"4","key":"10.1016\/j.ejpb.2026.115026_b0180","doi-asserted-by":"crossref","DOI":"10.1002\/adsu.202200469","article-title":"Exploiting the thermotropic behavior of hydroxypropyl cellulose to produce edible photonic pigments","volume":"7","author":"Ming","year":"2023","journal-title":"Adv. Sustain. Syst."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115026_b0185","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/pharmaceutics10020057","article-title":"Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems","volume":"10","author":"Danaei","year":"2018","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.ejpb.2026.115026_b0190","article-title":"Rheological properties of cholesteric liquid crystals as lubricant additives","volume":"33","author":"Madhavi","year":"2019","journal-title":"Int. J. Mod Phys B"},{"issue":"34","key":"10.1016\/j.ejpb.2026.115026_b0195","doi-asserted-by":"crossref","first-page":"9191","DOI":"10.1039\/D0SC03339A","article-title":"Conformation control through concurrent N-H\u22efS and N-H\u22efO=C hydrogen bonding and hyperconjugation effect","volume":"11","author":"Imani","year":"2020","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ejpb.2026.115026_b0200","doi-asserted-by":"crossref","unstructured":"B.A. Alkhalidi, H.S. AlKhatib, M. Saleh, S. Hamed, Y. Bustanji, N. Al Bujuq, N. Najib, S. Torrado-Susana, A.S. Sallam, Clarithromycin laurate salt: physicochemical properties and pharmacokinetics after oral administration in humans, Pharm. Dev. Technol. 24 (5) (2019) 607-615. DOI: 10.1080\/10837450.2018.1547749.","DOI":"10.1080\/10837450.2018.1547749"},{"key":"10.1016\/j.ejpb.2026.115026_b0205","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1107\/S0567740881006638","article-title":"Structure of N-acetyl-L-cysteine: X-ray (T = 295 K) and neutron (T = 16 K) diffraction studies","volume":"37","author":"Takusagawa","year":"1981","journal-title":"Acta Crystallogr. B"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115026_b0210","article-title":"Insights into the ethanol solvate form of clarithromycin","volume":"1264","author":"Mi\u00f1ambres","year":"2022","journal-title":"J. Mol. Struct."},{"issue":"5","key":"10.1016\/j.ejpb.2026.115026_b0215","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s10096-015-2323-z","article-title":"Biofilm-specific antibiotic tolerance and resistance","volume":"34","author":"Olsen","year":"2015","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115026_b0220","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3390\/pathogens13010076","article-title":"Biofilm producing methicillin-resistant Staphylococcus aureus (MRSA) infections in humans: clinical implications and management","volume":"13","author":"Kaushik","year":"2024","journal-title":"Pathogens"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126000470?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126000470?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:42:23Z","timestamp":1777592543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641126000470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":44,"alternative-id":["S0939641126000470"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115026","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From ascorbic acid to N-acetylcysteine: self-assembled clarithromycin liquid crystals as a new generation of carrier-free antibiotics","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115026"}}